Brian F. Clem
Impact in
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
- Molecular Biology top 5%
- Metabolism, Diabetes, and Cancer
- Epigenetics and DNA Methylation
- Mitochondrial Function and Pathology
- RNA modifications and cancer
Papers in
-
- Cancer, Hypoxia, and Metabolism 24
- Oncology 19
- Cancer-related Molecular Pathways 16
- Co-authors
- Jason Alan Chesney (27 shared papers)Sucheta Telang (20 shared papers)Abdullah Yalçın (8 shared papers)Amy L. Clem (12 shared papers)Andrew N. Lane (5 shared papers)Julie O’Neal (8 shared papers)John O. Trent (5 shared papers)Alden C. Klarer (7 shared papers)
- Journals
- Journal of Biological Chemistry (4 papers)Cancers (3 papers)Oncogene (3 papers)Endocrine Related Cancer (3 papers)Molecular Cancer Therapeutics (2 papers)
- Partner nations
- United StatesTürkiyeSpain
In The Last Decade
Brian F. Clem
47 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 106
- Cancer Research 1.7k
- Molecular Biology 2.0k
- Oncology 570
- Biochemistry 158
- Immunology 340
Countries citing papers authored by Brian F. Clem
This map shows the geographic impact of Brian F. Clem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian F. Clem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian F. Clem more than expected).
Fields of papers citing papers by Brian F. Clem
This network shows the impact of papers produced by Brian F. Clem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian F. Clem. The network helps show where Brian F. Clem may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian F. Clem, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 381 | |
| 2 | 2009 | 339 | |
| 3 | 2008 | 252 | |
| 4 | 2013 | 239 | |
| 5 | 2021 | 211 | |
| 6 | 2009 | 205 | |
| 7 | 2013 | 191 | |
| 8 | 2014 | 167 | |
| 9 | 2004 | 91 | |
| 10 | 2009 | 89 | |
| 11 | 2014 | 88 | |
| 12 | 2016 | 86 | |
| 13 | 2012 | 85 | |
| 14 | 2009 | 83 | |
| 15 | 2014 | 77 | |
| 16 | 2011 | 64 | |
| 17 | 2016 | 64 | |
| 18 | 2014 | 63 | |
| 19 | 2011 | 59 | |
| 20 | 2019 | 49 |
About Brian F. Clem
Brian F. Clem is a scholar working on Cancer Research, Oncology, Molecular Biology, Cell Biology and Biochemistry, having authored 48 papers that have together received 3.3k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (24 papers), Cancer-related Molecular Pathways (16 papers), Metabolism, Diabetes, and Cancer (8 papers), Epigenetics and DNA Methylation (6 papers), Microtubule and mitosis dynamics (5 papers), RNA modifications and cancer (4 papers), Mitochondrial Function and Pathology (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). The work is most often cited by research in Cancer Research (1.7k citations), Molecular Biology (2.0k citations), Oncology (570 citations), Biochemistry (158 citations) and Immunology (340 citations). Brian F. Clem has collaborated with scholars based in United States, Türkiye and Spain. Frequent co-authors include Jason Alan Chesney, Sucheta Telang, Abdullah Yalçın, Amy L. Clem, Andrew N. Lane, Julie O’Neal, John O. Trent, Alden C. Klarer, Yoannis Imbert-Fernandez and John W. Eaton. Their work appears in journals such as Journal of Biological Chemistry, Cancers, Oncogene, Endocrine Related Cancer and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.